CN111378675A - Biosynthesis gene of eremophilane sesquiterpene in catharanthus roseus and application - Google Patents

Biosynthesis gene of eremophilane sesquiterpene in catharanthus roseus and application Download PDF

Info

Publication number
CN111378675A
CN111378675A CN201811651116.6A CN201811651116A CN111378675A CN 111378675 A CN111378675 A CN 111378675A CN 201811651116 A CN201811651116 A CN 201811651116A CN 111378675 A CN111378675 A CN 111378675A
Authority
CN
China
Prior art keywords
leu
jinkoh
eremol
epi
debneyol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811651116.6A
Other languages
Chinese (zh)
Inventor
于荣敏
梁锦才
訾佳辰
朱建华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201811651116.6A priority Critical patent/CN111378675A/en
Publication of CN111378675A publication Critical patent/CN111378675A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y402/00Carbon-oxygen lyases (4.2)
    • C12Y402/03Carbon-oxygen lyases (4.2) acting on phosphates (4.2.3)

Abstract

The invention discloses an eremophilane sesquiterpene 5-epi-jinkoh-eremol and debneyol biosynthetic gene pair in Catharanthus roseus (Catharanthus roseus) and application thereof. The entire gene pair contains 2 genes: a gene encoding terpene synthase CrTPS3 and a gene encoding cytochrome P450 enzyme CrCPY. The biosynthesis of 5-epi-jinkoh-eremol and debneyol can be blocked or enhanced by genetic manipulation of the above biosynthetic genes. The gene and the protein thereof provided by the invention can be used for gene engineering, protein expression, enzyme catalytic reaction and the like of 5-epi-jinkoh-eremol and debneyol compounds, and can also be used for searching and discovering compounds or genes and proteins which can be used for medicine, industry or agriculture.

Description

Biosynthesis gene of eremophilane sesquiterpene in catharanthus roseus and application
Technical Field
The invention belongs to the technical field of plant genetic engineering and medicine, and particularly relates to a biosynthesis method and application of eremophilane sesquiterpene 5-epi-jinkoh-eremol and Debneyol with an antibacterial effect.
Background
Plant mycoses are diseases caused by phytopathogenic fungi. Accounts for about 70-80% of plant diseases, and is one of the main causes of yield reduction of economic plants. Several or even dozens of fungal diseases can be found in one crop, and common diseases include downy mildew, powdery mildew, white rust, black powder, rust powder, tobacco mold, black nevus, mildew, mushroom, cotton floc, granules, ropes, clay grains, small black spots and the like. The crop is infected with diseases to cause yield reduction and quality deterioration, and some pathogenic fungi (such as fusarium and aspergillus flavus) also generate various mycotoxins harmful to human and livestock in the process of infecting plants, so that the food safety is influenced. Many fungal diseases do not manifest signs at all when environmental conditions are inappropriate. The infection cycle types of fungal diseases are the most, many germs can form special tissues or spores to live through the winter, the damage cycle is long, and huge economic losses are caused. At present, methods for coping with plant fungal diseases are limited, and besides selecting good disease-resistant varieties and strengthening cultivation management, the method mainly depends on pesticide application for prevention and control. The existing plant fungi control drugs are mostly of microbial sources and have the defects of being environment-friendly, easy to resist drugs, easy to remain and the like. Therefore, the search for new and highly effective plant-derived antifungal agents is urgent.
Terpenoids in plants play an important role in their own chemical defense system and thus often have strong antifungal and antibacterial effects. Eremophilane (eremophilane) sesquiterpenes exist in various plants, and various eremophilane sesquiterpene derivatives are found to have antitumor effect. In addition, the eremophilane sesquiterpene also has strong antifungal effect. Wherein the eremophilane sesquiterpene debneyol found in the tobacco infected by the virus has better inhibiting effect on fungi such as Cladosporium cuprinum, Colletotrichum lindleyanum and the like, and the eremophilane sesquiterpene debneyol and the analogues thereof have the effect of resisting plant fungal diseases [ Phytochemistry,24,2191-219(1985) ]. At present, eremophilane sesquiterpenes are mainly obtained by a method of extracting from plants or chemically synthesizing, and have the defects of high energy consumption, environmental friendliness and the like. The eremophilane sesquiterpene is produced by excavating plant gene resources and utilizing a biosynthesis method, so that the new plant-derived eremophilane sesquiterpene with plant fungal disease resistance can be found in depth, and the method has practical significance for the development and utilization of the sesquiterpene.
Disclosure of Invention
The invention aims to overcome the defects of a plant fungal disease antibacterial agent from microorganisms, and determines the eremophilane sesquiterpene 5-epi-jinkoh-eremol and debneyol biosynthesis related gene pair CrTPS3-CrCYP by performing genome data analysis and biochemical function verification on a medicinal plant catharanthus roseus with strong anti-germ capacity. The antibacterial effect of 5-epi-jinkoh-eremol and debneyol in phytochemical defense is determined.
The invention provides a nucleotide sequence for coding terpene synthase CrTPS3, wherein the nucleotide sequence is positioned at the 1st to 1686 th base in SEQ ID NO.1, and the coded amino acid sequence is SEQ ID NO. 2.
The invention also provides a nucleotide sequence for coding the cytochrome P450 enzyme CrCYP, wherein the nucleotide sequence is positioned at the 1687-3201 base in SEQ ID NO.1, and the coded amino acid sequence is SEQ ID NO. 3.
The invention also provides a recombinant expression plasmid containing the CrTPS3 and CrCYP encoding genes, and a recombinant microorganism escherichia coli C41(DE3) and saccharomyces cerevisiae BY4741 containing the recombinant plasmid.
The invention discloses a biosynthesis way capable of efficiently producing 5-epi-jinkoh-eremol and Debneyol in Escherichia coli C41(DE3) and Saccharomyces cerevisiae BY4741, and the biosynthesis way can be used for producing 5-epi-jinkoh-eremol of more than or equal to 100mg/L and Debneyol of more than or equal to 3mg/L BY fermentation under laboratory conditions.
The invention also discloses the antibacterial action of eremophilane sesquiterpene 5-epi-jinkoh-eremol and debneyol on 3 common plant pathogenic fungi and 2 plant pathogenic bacteria.
Starting from cloning plant biosynthesis gene pairs, the biosynthesis is researched by adopting a method combining microbiology, molecular biology, biochemistry and organic chemistry, and the biosynthesis pathway of eremophilane sesquiterpenes 5-epi-jinkoh-eremol and debneyol is disclosed through the research on the biosynthesis mechanism. On the basis, the principle of metabolic engineering is applied, and the heterologous expression quantity of the 5-epi-jinkoh-eremol and debneyol is improved by reasonably optimizing a biosynthesis pathway by combining biology.
The application of eremophilane sesquiterpene 5-epi-jinkoh-eremol and debneyol biosynthetic gene pairs of the invention includes (but is not limited to):
(1) comprising the nucleotide sequence provided by the present invention or at least part of the nucleotide sequence may be modified or mutated. These include insertions, substitutions or deletions, polymerase chain reaction, error-mediated polymerase chain reaction, site-specific mutations, reconnection of different sequences, directed evolution of different parts of a sequence or homologous sequences from other sources, or mutagenesis by ultraviolet light or chemical reagents, and the like.
(2) Cloned genes comprising the nucleotide sequences provided by the invention or at least part of the nucleotide sequences can be expressed in an exogenous host by means of a suitable expression system to obtain the corresponding enzymes or other higher biological activity or yield. Such foreign hosts include Streptomyces, Pseudomonas, Escherichia, Bacillus, yeast, plants, and animals.
(3) The amino acid sequences provided by the invention can be used for separating the required protein and can be used for preparing antibodies.
(4) Polypeptides comprising the amino acid sequences or at least partial sequences provided herein may have biological activity, even new biological activity, after removal or substitution of certain amino acids, or increased yield or optimized protein kinetics or other properties sought to be achieved.
(5) Genes comprising the nucleotide sequences provided by the invention or at least part of the nucleotide sequences can be expressed in heterologous hosts and their function in the metabolic chain of the host is understood by DNA chip technology.
(6) The gene comprising the nucleotide sequence or at least part of the nucleotide sequence provided by the present invention can be used for constructing a recombinant plasmid through genetic recombination to obtain a novel biosynthetic pathway, and can also be used for obtaining a novel biosynthetic pathway through insertion, replacement, deletion or inactivation.
(7) The protein encoded by the nucleotide sequence provided by the invention can catalyze farnesyl pyrophosphate to synthesize 5-epi-jinkoh-eremol and debneyol, and can be recombined by a biosynthesis pathway or a partial biosynthesis pathway with other natural products to obtain the novel eremophane sesquiterpene compounds.
Therefore, a recombinant vector, an expression cassette, a transgenic cell line or a recombinant bacterium containing the above gene pair is also within the scope of the present invention.
The application of the protein, the gene cluster, the recombinant vector, the expression cassette, the transgenic cell line or the recombinant bacteria in the synthesis of 5-epi-jinkoh-eremol and debneyol is also within the protection scope of the invention.
Another objective of the invention is to provide a method for synthesizing 5-epi-jinkoh-eremol and debneyol, which is to ferment the recombinant bacteria and collect fermentation products to obtain the eremophilane sesquiterpene 5-epi-jinkoh-eremol and debneyol compounds.
In conclusion, the information of all genes and proteins related to 5-epi-jinkoh-eremol and debneyol biosynthesis provided by the invention can help people to understand the biosynthesis mechanism of eremophilane sesquiterpene compounds, and provides materials and knowledge for further genetic modification. The gene and the protein thereof provided by the invention can also be used for searching and discovering compounds or genes and proteins which can be used for medicine, industry or agriculture.
Description of the drawings
FIG. 1 biosynthetic pathway of 5-epi-jinkoh-eremol and Debneyol in Catharanthus roseus;
FIG. 2 shows the GC-MS detection result of the catalytic generation of 5-epi-jinkoh-eremol in Saccharomyces cerevisiae by CrTPS 3;
FIG. 3 GC-MS detection of the catalytic formation of 5-epi-jinkoh-eremol in E.coli by CrTPS 3;
FIG. 4 shows the GC-MS detection result of Debneyol catalyzed by CrCYP in Saccharomyces cerevisiae;
FIG. 5 shows the GC-MS detection result of Debneyol catalyzed by CrCYP in E.coli;
FIG. 6. optimization results of 5-epi-jinkoh-eremol biosynthetic pathway in Saccharomyces cerevisiae;
FIG. 7.5-zone of inhibition of epi-jinkoh-eremol and Debneyol against Rhizoctonia solani;
FIG. 8.5-epi-jinkoh-eremol and Debneyol quantification of zone of inhibition against Rhizoctonia solani;
FIG. 9.5-zone of inhibition of epi-jinkoh-eremol and Debneyol against early blight of tomato;
FIG. 10.5-epi-jinkoh-eremol and Debneyol quantification results of inhibition zones for early blight of tomato;
FIG. 11.5 zone of inhibition of F.oxysporum by epi-jinkoh-eremol and Debneyol;
FIG. 12.5-epi-jinkoh-eremol and Debneyol quantification results for inhibition zones of Fusarium oxysporum.
Fifth, detailed description of the invention
The invention is further illustrated by the following specific examples in conjunction with the accompanying drawings. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention. Experimental procedures without specific conditions noted in the following examples, molecular cloning is generally performed according to conventional conditions such as Sambrook et al: the conditions described in the laboratory Manual (New York: Cold spring harbor laboratory Press,1989), or according to the manufacturer's recommendations. Percentages and parts are by weight unless otherwise indicated.
Example 1
Catharanthus roseus RNA extraction and CrTPS3-CrCYP gene cloning
cDNA sequence of vinca sesquiterpene 5-epi-jinkoh-eremol and Debneyol synthetase gene in vinca genomeThe biosynthetic pathway is shown in FIG. 1. Using Trizol (Invitrogen) separately according to the kit instructionsTM) And HiScript II 1st Strand cDNA Synthesis Kit (Novozam Vazyme) for the extraction of total RNA from Catharanthus roseus leaves and reverse transcription to synthesize cDNA. The full-length coding sequences of the 5-epi-jinkoh-eremol synthetase gene CrTPS3 and the Debneyol synthetase gene CrTPS3 were amplified using two pairs of primers (CrTPS 3-F/R; CrCYP-F/R), and the amplified products were purified by electrophoresis and ligated with a blunt-end cloning vector pEASY-blunt (all-type gold) for DNA sequencing.
Example 2
Construction of Saccharomyces cerevisiae expression vector
For improving the content of farnesyl pyrophosphate serving as a precursor for sesquiterpene synthesis in saccharomyces cerevisiae, farnesyl pyrophosphate synthetase gene ERG20 and truncated hydroxymethyl glutaryl coenzyme A reductase gene tHMGp are respectively constructed on a pESC-LEU vector by a homologous recombination method to obtain two plasmids of pESC-LEU-ERG20 and pESC-LEU-tHMGp; for the biosynthesis of 5-epi-jinkoh-eremol, the full-length sequence of CrTPS3 is respectively constructed on pESC-LEU-ERG20 and pESC-LEU-tHMGp vectors by a homologous recombination method after AACA is added at the 5' end, so as to obtain two plasmids of pESC-LEU-ERG20-CrTPS3 and pESC-LEU-tHMGp-CrTPS 3; for the biosynthesis of Debneyol, the full-length sequence of CrCYP is added with AACA at the 5' end and then constructed on a pESC-URA vector by a homologous recombination method to obtain a pESC-URA-CrCYP plasmid; because the oxidation function of CrCYP needs to participate in NADPH dependent cytochrome P450 reductase, AtR1 of Arabidopsis thaliana is inserted into pESC-URA-CrCYP vector by using a homologous recombination method to obtain pESC-URA-CrCYP-AtR1 plasmid, and AtR1 of Arabidopsis thaliana is inserted into pESC-URA vector by using the homologous recombination method to obtain pESC-URA-AtR1 plasmid in order to provide negative control in biochemical function verification.
Example 3
Construction of E.coli expression vectors
In order to optimize the content of farnesyl pyrophosphate in Escherichia coli, ERG20 was inserted into pETDuet-1 vector by homologous recombination to obtain pETDuet-1-ERG20 plasmid; for the biosynthesis of 5-epi-jinkoh-eremol, the full-length sequence of CrTPS3 is inserted into a pETDuet-1-ERG20 vector by a homologous recombination method to obtain a pETDuet-1-ERG20-CrTPS3 plasmid; for the biosynthesis of Debneyol, the full-length sequence of the CrCYP is firstly truncated by 108bp at the 5' end and connected with a section of peptization peptide MAKKTSSKGKLPPGPS, and then the CrCYP is inserted into a pACYCDuet-1 vector by a homologous recombination method to obtain a pACYCDuet-1-CrCYP plasmid; similarly, the plasmid pACYCDuet-1-AtR1 and pACYCDuet-1-CrCYP-AtR1 are obtained by inserting AtR1 into the vectors pACYCDut-1 and pACYCDut-1-CrCYP by homologous recombination.
Example 4
Biosynthesis of the antibacterial sesquiterpenes Debneyol and 5-epi-jinkoh-eremol in Saccharomyces cerevisiae
For the strain for biosynthesis of 5-epi-jinkoh-eremol, only pESC-LEU-tHMGp-CrTPS3 plasmid needs to be transformed into Saccharomyces cerevisiae BY 4741; for the strain for biosynthesis of Debneyol, simultaneous transformation of pESC-LEU-ERG20-CrTPS3 plasmid and pESC-URA-CrCYP-AtR1 plasmid into BY4741 was required. The transformed strain was inoculated into 5ml SD medium, shake-cultured overnight at 30 ℃ and 220RPM, and then inoculated into 50ml SG (synthetic Galactose minimum Dropout Medium) medium at a ratio of 1:50 the next day, and shake-cultured at 30 ℃ and 220RPM for 5 days. Extracting the 5-epi-jinkoh-eremol fermentation liquor by using normal hexane to obtain a 5-epi-jinkoh-eremol crude extract, and extracting the Debneyol fermentation liquor by using ethyl acetate to obtain a Debneyol crude extract. Plasmid transformation of all saccharomyces cerevisiae strains in this experiment was based on the electroporation transformation method: adding 40ul of saccharomyces cerevisiae shock competence and 300ng of plasmid DNA into an EP tube, gently mixing, transferring into a precooled 2mm specification shock cup, quickly placing into a BIO-RAD MicroPulser shock tank, selecting a Sc2 mode for shock transformation, immediately resuspending the competence cells in the shock cup with 1M sorbitol after the shock is finished, transferring into the EP tube, incubating at 30 ℃ for 1 hour, coating in SD (synthetic Dextrose Minimal DropouthMedium) culture with corresponding auxotrophy, and carrying out inverted culture at 30 ℃ for 48-72 hours.
Example 5
Biosynthesis of antibacterial sesquiterpenes in E.coli
For the biosynthesis of 5-epi-jinkoh-eremol, the pIRS plasmid (Cyr, A.; Wilderman, P.R.; Determan, M.; Peters, R.J.J.J.am.chem.Soc.2007, 129,6684.) and pETDuet-1-ERG20-CrTPS3 plasmid were transformed simultaneously, for the biosynthesis of Debneol, the pIRS plasmid, pETDuet-1-ERG20-Cr 3 and CYpACDuet-1-CrCYP-AtR 1 plasmid were transformed simultaneously, positive clones were picked directly into 5ml TB medium containing the corresponding antibiotic at the time of biosynthesis of 5-epi-jinkoh-eremol, activated at 37 ℃ at 220RPM for 4 hours, then inoculated into 50ml TB medium containing the corresponding antibiotic at a ratio of 1:50, the strain was cultured at 37 ℃ at 0.600 ℃ for 0.6.7.7 ℃ in a gentle stroke of 5-100 min, the strain was inoculated into a gentle tapping of the strain, and the E.C.E.E.B.E.coli was extracted immediately after incubation with the heat-DNA at 37 ℃ for 5-10 min, and the strain was added to 5-100 min, and the E.7 min under a gentle tapping of the expression of the strain, and the strain was added to the E.E.C.16-E.E.E.E.C.E.coli strain was added to induce the expression of the strain, and the strain was added to the strain was expressed in a gentle strain under the conditions of the heat-strain under the heat-strain, and the conditions of the strain, the strain was added to induce the strain, the strain was added to the strain, the strain was added to the strain, the strain was added to the strain, the strain was added to the strain, the strain was added to.
Example 6
Detection, separation and purification of antibacterial sesquiterpene
The detection of 5-epi-jinkoh-eremol and Debneyol is based on gas mass spectrometry: dissolving and diluting a sample to be detected by using n-hexane, and carrying out gas phase mass spectrometry according to the following conditions, wherein the sample injection amount is 1ul, the sample injection is not carried out in a split-flow manner, the sample injection inlet temperature is 250 ℃, the oven temperature is kept at 50 ℃ for 3 minutes, then the rate of 20 ℃ per minute is increased to 70 ℃ for 1 minute, and then the rate of 15 ℃ per minute is increased to 300 ℃ for 3 minutes. Electron Ionization ion source, energy intensity 70 eV. Ultrasonically extracting the fermentation liquor for 20 minutes by using n-hexane or ethyl acetate with the same volume, carrying out rotary evaporation drying on an organic layer under the reduced pressure condition, redissolving the organic layer in 5ml of n-hexane, then passing through a 200-mesh 300-mesh silica gel column according to the proportion of 1:40, eluting the silica gel column by using n-hexane with the volume of 6 times of the column volume after loading, and then carrying out 40: 1 elution 6 column volumes, followed by n-hexane acetone 30: 1 eluted 3 column volumes followed by n-hexane acetone 20:1 eluting 3 column volumes followed by 10:1 eluting 3 column volumes. Fractions containing the desired product were combined, concentrated and further purified by HPLC using C18 reverse phase column chromatography with methanol in water as the mobile phase, followed by 70% methanol for 30 min and then 100% methanol for 10 min. Fractions containing the target product were analyzed by gas mass spectrometry, combined, blown dry with nitrogen, and dissolved in deuterated chloroform for NMR analysis. As shown in FIGS. 2 to 6, 5-epi-jinkoh-eremol and Debneyol compounds can be heterologously produced with high efficiency BY expressing a gene cluster comprising CrTPS3 and CrCYP genes in Saccharomyces cerevisiae BY4741 and Escherichia coli E.coli C41(DE 3).
Example 7
Inhibition of phytopathogenic fungi by 5-epi-jinkoh-eremol and Debneyol
Respectively dissolving 5-epi-jinkoh-eremol and Debneyol in DMSO (dimethylsulfoxide), preparing a potato glucose agar (PDA) culture medium, respectively adding the culture medium to a final concentration of 50mg/l when the culture medium is cooled to 50 ℃, adding DMSO (dimethyl sulfoxide) with the same volume in a blank control group, respectively inoculating rhizoctonia solani, early blight of tomato and fusarium oxysporum after preparing a PDA culture dish, culturing for 72 hours at 28 ℃, and measuring the size of a colony. 5-epi-jinkoh-eremol and Debneyol are respectively prepared into 1.5mg/ml to-be-detected solution by DMSO. Selecting pseudomonas syringae/xanthomonas campestris, carrying out monoclonal inoculation on the pseudomonas syringae/xanthomonas campestris, inoculating the pseudomonas syringae/xanthomonas campestris into 3ml KB/NYG liquid culture medium containing 50mg/L Rif, culturing the liquid culture medium at 30 ℃ and 220RPM until OD600 is 1.0-1.5, preparing 50ml of agar KB/NYG culture medium with 1.5 percent, adding 50mg/L Rif and 1ml of pseudomonas syringae/xanthomonas campestris bacterial liquid when the culture medium is cooled to 50 ℃, shaking up gently to prepare a solid culture plate, punching a puncher with the diameter of 0.5mm after bacterial plaque is solidified, adding 20ul of solution to be tested into the hole, culturing the liquid culture plate at 30 ℃ for 48 hours, and measuring the size of a colony. As shown in fig. 7-12. The 5-epi-jinkoh-eremol and debneyol compounds have remarkable antibacterial effects on 3 plant fungal diseases of rhizoctonia solani, early blight of tomato and fusarium oxysporum, wherein the debneyol has the best antibacterial effect on the early blight of tomato; 5-epi-jinkoh-eremol has the best antibacterial effect on rhizoctonia solani.
Figure BDA0001933019230000081
Figure BDA0001933019230000091
Figure BDA0001933019230000101
Figure BDA0001933019230000111
Figure BDA0001933019230000121
Figure BDA0001933019230000131
Figure BDA0001933019230000141
Figure BDA0001933019230000151
Figure BDA0001933019230000161
Figure BDA0001933019230000171
Figure BDA0001933019230000181
Figure BDA0001933019230000191
Figure BDA0001933019230000201
Figure BDA0001933019230000211
Sequence listing
<110> Yirongming
<120> eremophilane sesquiterpene biosynthesis gene in catharanthus roseus and application
<130>2018.12.27
<160>3
<170>SIPOSequenceListing 1.0
<210>1
<211>3201
<212>DNA
<213>Catharanthus roseus
<400>1
atgggcaggg aagtagtgat aatgatggct tctttcgtcg acaatggggt tcttcgtcca 60
ataaaaaaat tccctcctag catatggggt gataccttca attctttcga gtgggatcat 120
gaggcatcag aaaaacttgg caaggaaatg aaaatattgg aaaaagatgc gaggaacatg 180
ttacaagctg atacaagaaa tgagacagta aaggacataa ttactttgat caatactttt 240
gagcggctcg ggctttcgta taagtttgag aaagagatag aagatcatct ggaacgactt 300
gtccattctt ttgattatga tggaaatcaa catgatttgc tcacggtttc tctcctgttt 360
agaattctca ggcaacacgg atatgaaatc tcctcaggta tcttcaaaaa attcatggac 420
aagaatgggg aatttaaaga agagatcatt ggcaatgatg tgaaaggtgt attaagcctg 480
tatgaagcat cttacgtgag ggggcatgga gaagatattc ttgaaaaagc attggttttt 540
acaaaaggcc atctcatgag aattcttcct gaaataatag aatctcctct tggaaaacaa 600
gtaatatatg ctcttgaaca accactccat agaggtgttc caagacttga ggctcgtcat 660
tacatctcca tttatgagga agaccaagaa actaaaaatg aagcacttct tagactcgca 720
aaattggatt tcaatctatt gcaaatgtta cacaagaaag agatatgtga gattacaagg 780
tggtggaaga aatcggactt tatgggaaaa cttccttatc taagagatag ggtggtggaa 840
tgctattttt gggcaatagg aatatacttt gaacctaagt attctcttgc tcgtataatg 900
gccagcaaag ttgtggccat gacttcaatc atggatgaca cctatgactc ttatggcata 960
attgaagaac ttgaagtttt cacttctgct gtcgaaaggt ggagcattga agaaattgat 1020
agactcccaa gttacatgaa gatagcctac atggcacttc tcaacctgta cgaagaattt 1080
gatgaaaaac taaaagaaca gggacgatcc tttgcagttc aatattccaa agaaagaatg 1140
aagcagctaa taagaagcta tgacaaagaa gctaagtggt tttatgaaag atcagatgat 1200
gtgcctagtt ttgatgaata catggaaaat gcaatatcaa ctagcactta cctcgtactc 1260
atgccgtcgt tgttgttggg gatggaatct gcaagcaggg aagtgtttga ttgggtcatg 1320
aacaatccta gtatagttgt ggctagtgcc aaagttggtc gatgcacaga cgacgtcgct 1380
acttattcgg ttgagaaagc aaggggtcaa ccagcctgcg gaatcgaatg gtacatgaaa 1440
gaacatggtg tctctaaaga agaaactttc aaaaaatttc atgaaattgt tgaagattct 1500
tggaaagata ttaataagga acttgtccga tcatcctcga ttccaatgga tattctagtg 1560
agggctttaa accaagcaag agtgatcgac gtggtttata agcatgatca agatggttat 1620
actcaccctg aaaaggttct caaaccccat atcaaggcct tacttgttga tcctataagc 1680
atttgaatgg gctttcagat tcctttaaac ttcattgcct tctttgtatt cctattgttg 1740
tcttctattt tattagtgaa acagaggaat agaaaatcat taggaaagaa aaaactgccc 1800
ccaggacccc ggaagttacc attgattgga aacctacaca atttgatagg tggacttcct 1860
catcatattt tcagagattt atctcgaaaa tatggacctc ttattcacct acaattgggt 1920
caagtaggta ccattttgat atcttcacca cgtttagcaa aagaggtgat gaaaactcat 1980
gatcttacct ttgcaacaag gccggacaat cttgccggag atgtcatgtt ctatggtagc 2040
acagatattg tatttgccaa atacggcgag tactggagac aaatgcgtaa aatcagtgtc 2100
ttagaactct tcagcgcgaa aaatgtccgg tcatttggtt ctataagaat ggatgaatca 2160
ttacttatga ttgcgtctat acgagaatca gttggtaaag cggttaatct aagcacaaaa 2220
cttgcaaact atacaagttc tgtggtttgc agggcagcat ttggtaggtt atgtcctgac 2280
caacatgagt ttattgagtt agttgatgaa gcatctgttt tagcagcagg ctttgatatt 2340
ggtgaccttt ttccatcatt aaagtttatt cagtttttga ctggattaaa gcctaaatta 2400
atgaaggttc ataataaggt tgacaagatt ttggaccatg taattaatga gcatagaaaa 2460
aacatgggaa ggagaaatgg tgagtttggt gaagaagact taactgattc acttctaaga 2520
attcaacaaa gtggtggtga ccttcaattt cccatctccg acaacaatat taaggcaatc 2580
ttgtttgatg tgtttggtgc gggaacagaa acttcatcca caataacaga atgggccttg 2640
tcagaattaa ttaaaaatcc agatatgatg aacaaggcac aaactgaaat aaggcaagcc 2700
ttcaagggaa agaaaaggcc gattgaagag gctgatcttc aaggcctaag ttatctcaag 2760
tgtgtaatta aagaaacact gaggctatat cctgcagcgc ctttattggt tcctcgtgaa 2820
tgcagagagg actgtgaatt ggatggatat tttataccaa agaaatcaag ggtaattgtt 2880
aatgcttggg caattggaag agatcctgag tattggccta atgcaaacag ttttattccc 2940
gaaagatttg agaattcttc aactgatttc accggtaatc actttgaatt aataccattt 3000
gggtcaggaa ggaggagttg tcctggaatg ctgtttggta tagctaatat tgagcttcct 3060
ttagctcttc ttttatacca cttcaactgg agtctcccag atggccttac ttccgaaact 3120
ttggacatgt ctgagacttg gggaataaca actccaagga aatatgatct tcacctaatc 3180
cctacatctt attatcctta a 3201
<210>2
<211>561
<212>PRT
<213>Catharanthus roseus
<400>2
Met Gly Arg Glu Val Val Ile Met Met Ala Ser Phe Val Asp Asn Gly
1 5 10 15
Val Leu Arg Pro Ile Lys Lys Phe Pro Pro Ser Ile Trp Gly Asp Thr
20 25 30
Phe Asn Ser Phe Glu Trp Asp His Glu Ala Ser Glu Lys Leu Gly Lys
35 40 45
Glu Met Lys Ile Leu Glu Lys Asp Ala Arg Asn Met Leu Gln Ala Asp
50 55 60
Thr Arg Asn Glu Thr Val Lys Asp Ile Ile Thr Leu Ile Asn Thr Phe
65 70 75 80
Glu Arg Leu Gly Leu Ser Tyr Lys Phe Glu Lys Glu Ile Glu Asp His
85 90 95
Leu Glu Arg Leu Val His Ser Phe Asp Tyr Asp Gly Asn Gln His Asp
100 105 110
Leu Leu Thr Val Ser Leu Leu Phe Arg Ile Leu Arg Gln His Gly Tyr
115 120 125
Glu Ile Ser Ser Gly Ile Phe Lys Lys Phe Met Asp Lys Asn Gly Glu
130 135 140
Phe Lys Glu Glu Ile Ile Gly Asn Asp Val Lys Gly Val Leu Ser Leu
145 150 155 160
Tyr Glu Ala Ser Tyr Val Arg Gly His Gly Glu Asp Ile Leu Glu Lys
165 170 175
Ala Leu Val Phe Thr Lys Gly His Leu Met Arg Ile Leu Pro Glu Ile
180 185 190
Ile Glu Ser Pro Leu Gly Lys Gln Val Ile Tyr Ala Leu Glu Gln Pro
195 200 205
Leu His Arg Gly Val ProArg Leu Glu Ala Arg His Tyr Ile Ser Ile
210 215 220
Tyr Glu Glu Asp Gln Glu Thr Lys Asn Glu Ala Leu Leu Arg Leu Ala
225 230 235 240
Lys Leu Asp Phe Asn Leu Leu Gln Met Leu His Lys Lys Glu Ile Cys
245 250 255
Glu Ile Thr Arg Trp Trp Lys Lys Ser Asp Phe Met Gly Lys Leu Pro
260 265 270
Tyr Leu Arg Asp Arg Val Val Glu Cys Tyr Phe Trp Ala Ile Gly Ile
275 280 285
Tyr Phe Glu Pro Lys Tyr Ser Leu Ala Arg Ile Met Ala Ser Lys Val
290 295 300
Val Ala Met Thr Ser Ile Met Asp Asp Thr Tyr Asp Ser Tyr Gly Ile
305 310 315 320
Ile Glu Glu Leu Glu Val Phe Thr Ser Ala Val Glu Arg Trp Ser Ile
325 330 335
Glu Glu Ile Asp Arg Leu Pro Ser Tyr Met Lys Ile Ala Tyr Met Ala
340 345 350
Leu Leu Asn Leu Tyr Glu Glu Phe Asp Glu Lys Leu Lys Glu Gln Gly
355 360 365
Arg Ser Phe Ala Val Gln Tyr SerLys Glu Arg Met Lys Gln Leu Ile
370 375 380
Arg Ser Tyr Asp Lys Glu Ala Lys Trp Phe Tyr Glu Arg Ser Asp Asp
385 390 395 400
Val Pro Ser Phe Asp Glu Tyr Met Glu Asn Ala Ile Ser Thr Ser Thr
405 410 415
Tyr Leu Val Leu Met Pro Ser Leu Leu Leu Gly Met Glu Ser Ala Ser
420 425 430
Arg Glu Val Phe Asp Trp Val Met Asn Asn Pro Ser Ile Val Val Ala
435 440 445
Ser Ala Lys Val Gly Arg Cys Thr Asp Asp Val Ala Thr Tyr Ser Val
450 455 460
Glu Lys Ala Arg Gly Gln Pro Ala Cys Gly Ile Glu Trp Tyr Met Lys
465 470 475 480
Glu His Gly Val Ser Lys Glu Glu Thr Phe Lys Lys Phe His Glu Ile
485 490 495
Val Glu Asp Ser Trp Lys Asp Ile Asn Lys Glu Leu Val Arg Ser Ser
500 505 510
Ser Ile Pro Met Asp Ile Leu Val Arg Ala Leu Asn Gln Ala Arg Val
515 520 525
Ile Asp Val Val Tyr Lys His Asp Gln AspGly Tyr Thr His Pro Glu
530 535 540
Lys Val Leu Lys Pro His Ile Lys Ala Leu Leu Val Asp Pro Ile Ser
545 550 555 560
Ile
<210>3
<211>504
<212>PRT
<213>Catharanthus roseus
<400>3
Met Gly Phe Gln Ile Pro Leu Asn Phe Ile Ala Phe Phe Val Phe Leu
1 5 10 15
Leu Leu Ser Ser Ile Leu Leu Val Lys Gln Arg Asn Arg Lys Ser Leu
20 25 30
Gly Lys Lys Lys Leu Pro Pro Gly Pro Arg Lys Leu Pro Leu Ile Gly
35 40 45
Asn Leu His Asn Leu Ile Gly Gly Leu Pro His His Ile Phe Arg Asp
50 55 60
Leu Ser Arg Lys Tyr Gly Pro Leu Ile His Leu Gln Leu Gly Gln Val
65 70 75 80
Gly Thr Ile Leu Ile Ser Ser Pro Arg Leu Ala Lys Glu Val Met Lys
85 90 95
Thr His Asp Leu Thr Phe Ala Thr Arg Pro Asp Asn Leu Ala Gly Asp
100 105 110
Val Met Phe Tyr Gly Ser Thr Asp Ile Val Phe Ala Lys Tyr Gly Glu
115 120 125
Tyr Trp Arg Gln Met Arg Lys Ile Ser Val Leu Glu Leu Phe Ser Ala
130 135 140
Lys Asn Val Arg Ser Phe Gly Ser Ile Arg Met Asp Glu Ser Leu Leu
145 150 155 160
Met Ile Ala Ser Ile Arg Glu Ser Val Gly Lys Ala Val Asn Leu Ser
165 170 175
Thr Lys Leu Ala Asn Tyr Thr Ser Ser Val Val Cys Arg Ala Ala Phe
180 185 190
Gly Arg Leu Cys Pro Asp Gln His Glu Phe Ile Glu Leu Val Asp Glu
195 200 205
Ala Ser Val Leu Ala Ala Gly Phe Asp Ile Gly Asp Leu Phe Pro Ser
210 215 220
Leu Lys Phe Ile Gln Phe Leu Thr Gly Leu Lys Pro Lys Leu Met Lys
225 230 235 240
Val His Asn Lys Val Asp Lys Ile Leu Asp His Val Ile Asn Glu His
245 250 255
Arg Lys Asn Met Gly Arg Arg Asn Gly Glu Phe Gly Glu Glu Asp Leu
260 265 270
Thr Asp Ser Leu Leu Arg Ile Gln Gln Ser Gly Gly Asp Leu Gln Phe
275 280 285
Pro Ile Ser Asp Asn Asn Ile Lys Ala Ile Leu Phe Asp Val Phe Gly
290 295 300
Ala Gly Thr Glu Thr Ser Ser Thr Ile Thr Glu Trp Ala Leu Ser Glu
305 310 315 320
Leu Ile Lys Asn Pro Asp Met Met Asn Lys Ala Gln Thr Glu Ile Arg
325 330 335
Gln Ala Phe Lys Gly Lys Lys Arg Pro Ile Glu Glu Ala Asp Leu Gln
340 345 350
Gly Leu Ser Tyr Leu Lys Cys Val Ile Lys Glu Thr Leu Arg Leu Tyr
355 360 365
Pro Ala Ala Pro Leu Leu Val Pro Arg Glu Cys Arg Glu Asp Cys Glu
370 375 380
Leu Asp Gly Tyr Phe Ile Pro Lys Lys Ser Arg Val Ile Val Asn Ala
385 390 395 400
Trp Ala Ile Gly Arg Asp Pro Glu Tyr Trp Pro Asn Ala Asn Ser Phe
405 410 415
Ile Pro Glu Arg Phe Glu Asn Ser Ser Thr Asp Phe Thr Gly Asn His
420425 430
Phe Glu Leu Ile Pro Phe Gly Ser Gly Arg Arg Ser Cys Pro Gly Met
435 440 445
Leu Phe Gly Ile Ala Asn Ile Glu Leu Pro Leu Ala Leu Leu Leu Tyr
450 455 460
His Phe Asn Trp Ser Leu Pro Asp Gly Leu Thr Ser Glu Thr Leu Asp
465 470 475 480
Met Ser Glu Thr Trp Gly Ile Thr Thr Pro Arg Lys Tyr Asp Leu His
485 490 495
Leu Ile Pro Thr Ser Tyr Tyr Pro
500

Claims (4)

1. A biosynthetic gene pair derived from eremophilane sesquiterpenes 5-epi-jinkoh-eremol and debneyol in Catharanthus roseus (Catharanthus roseus), characterized in that the nucleotide sequence of the gene cluster is shown as 1-3201 in SEQ ID NO. 1; the genes for coding eremophilane sesquiterpene 5-epi-jinkoh-eremol and debneyol biosynthesis related genes included in the gene pair are specifically as follows:
1) a nucleotide sequence for coding terpene synthase CrTPS3 is located at 1-1686 base of SEQ ID NO.1, and the coded amino acid sequence is SEQ ID NO. 2.
2) A nucleotide sequence for coding a cytochrome P450 enzyme CrCYP, wherein the nucleotide sequence is positioned at 1687-3201 base in SEQ ID NO.1, and the coded amino acid sequence is SEQ ID NO. 3.
2. A recombinant vector, expression cassette, transgenic cell line or recombinant bacterium comprising the biosynthetic gene pair of eremophilane sesquiterpenes 5-epi-jinkoh-eremol and debneyol of claim 1.
3. Use of the recombinant vector, expression cassette, transgenic cell line or recombinant bacterium of claim 1 for the synthesis of 5-epi-jinkoh-eremol and debneyol.
4. A method for synthesizing 5-epi-jinkoh-eremol and debneyol, which is the recombinant bacterium in claim 3, and collecting and extracting fermentation products to obtain the 5-epi-jinkoh-eremol and debneyol compounds.
CN201811651116.6A 2018-12-31 2018-12-31 Biosynthesis gene of eremophilane sesquiterpene in catharanthus roseus and application Pending CN111378675A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811651116.6A CN111378675A (en) 2018-12-31 2018-12-31 Biosynthesis gene of eremophilane sesquiterpene in catharanthus roseus and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811651116.6A CN111378675A (en) 2018-12-31 2018-12-31 Biosynthesis gene of eremophilane sesquiterpene in catharanthus roseus and application

Publications (1)

Publication Number Publication Date
CN111378675A true CN111378675A (en) 2020-07-07

Family

ID=71216186

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811651116.6A Pending CN111378675A (en) 2018-12-31 2018-12-31 Biosynthesis gene of eremophilane sesquiterpene in catharanthus roseus and application

Country Status (1)

Country Link
CN (1) CN111378675A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114107233A (en) * 2021-10-27 2022-03-01 武汉臻智生物科技有限公司 Phosetrene synthetase gene, high-yield strain and application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107119034A (en) * 2017-05-08 2017-09-01 四川农业大学 A kind of ZmEDS genes and its encoding proteins, rite-directed mutagenesis gene and application

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107119034A (en) * 2017-05-08 2017-09-01 四川农业大学 A kind of ZmEDS genes and its encoding proteins, rite-directed mutagenesis gene and application

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JINCAI LIANG,等: "Mining of the Catharanthus roseus Genome Leads to Identification of a Biosynthetic Gene Cluster for Fungicidal Sesquiterpenes", 《J NAT PROD》 *
ZI,J.: "MN102096", 《GENBANK》 *
ZI,J.: "MN102097", 《GENBANK》 *
曾俊岚等: "长春花生物碱合成途径相关基因表达丰度与MeJA处理后基因表达差异分析", 《基因组学与应用生物学》 *
梁锦才,等: "基于合成生物学方法体系研究和发现植物源活性萜类化合物", 《第十一届全国化学生物学学术会议》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114107233A (en) * 2021-10-27 2022-03-01 武汉臻智生物科技有限公司 Phosetrene synthetase gene, high-yield strain and application
CN114107233B (en) * 2021-10-27 2024-01-09 武汉合生科技有限公司 Synthetase gene of phorene, high-yield strain and application

Similar Documents

Publication Publication Date Title
KR101814888B1 (en) 5-aminolevulinic acid high-yield bacterial strain, preparation method and uses thereof
CN109825484B (en) Zearalenone hydrolase ZHD101 mutant and method for hydrolyzing zearalenone by using mutant
CN111868047A (en) Nepetalactol oxidoreductase, nepetalactol synthase and microorganism capable of producing nepetalactone
CN109055327A (en) Aldehyde Ketoreductase mutant and its application
CN109097343A (en) 11 B-hydroxylase of steroid and its encoding gene and application in Curvuluria Iunata
CN102965355B (en) Carboxylesterase and application thereof in degradation of pesticides malathion and carbaryl
CN109055324A (en) A kind of improved ketoreductase and its application
CN111088254B (en) Endogenous carried exogenous gene efficient controllable expression system
CN108034667A (en) A kind of red monascus alpha-amylase gene, its preparation method and application
JP2002535346A (en) Methods for controlling fungal pathogens and substances useful therefor
CN110885840A (en) Method for increasing yield of cellulase produced by trichoderma reesei
CN104630100A (en) Reconstructed Klebsiella pneumoniae and application of reconstructed Klebsiella pneumoniae in production of R-acetoin
CN109576239A (en) Heat-resisting phosphorylase and its application
CN111118037B (en) Gene DICX4 with herbicide dicamba degradation function and application thereof
CN111378675A (en) Biosynthesis gene of eremophilane sesquiterpene in catharanthus roseus and application
CN111718917B (en) Thermostable bacteria quorum sensing signal degrading enzyme and application thereof
WO2020042697A1 (en) Recombinant microorganism, preparation method therefor and application thereof in producing coenzyme q10
AU2012260431A1 (en) Fungi and products thereof
CN113265391B (en) Linalool synthase CcLS and coding gene and application thereof
CN111621452A (en) Bacillus subtilis for producing D-p-hydroxyphenylglycine
CN115873836A (en) Nerolidol synthetase and application thereof
Santhanam et al. A reassessment of flocculosin-mediated biocontrol activity of Pseudozyma flocculosa through CRISPR/Cas9 gene editing
CN110607311B (en) DSF quorum sensing signal degradation gene and application thereof
CN112143689B (en) Construction of recombinant pseudomonas putida strain and application thereof in conversion of threonine to synthesize propionic acid
CN113980945B (en) Trichoderma viride histone deacetylase and encoding gene and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200707